These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16342656)

  • 41. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.
    Ezekowitz JA; McAlister FA
    Eur Heart J; 2009 Feb; 30(4):469-77. PubMed ID: 19066207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886
    [No Abstract]   [Full Text] [Related]  

  • 43. [The revived interest in aldosterone antagonists].
    Waeber B
    Rev Med Suisse; 2006 Sep; 2(78):2055-8. PubMed ID: 17019841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
    Aaronson K
    Health News; 2003 May; 9(5):4. PubMed ID: 12739453
    [No Abstract]   [Full Text] [Related]  

  • 46. Hyperkalaemia in the age of aldosterone antagonism.
    Chapagain A; Ashman N
    QJM; 2012 Nov; 105(11):1049-57. PubMed ID: 22723454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aldosterone receptor antagonists--how cardiovascular actions may explain their beneficial effects in heart failure.
    Ovaert P; Elliott J; Bernay F; Guillot E; Bardon T
    J Vet Pharmacol Ther; 2010 Apr; 33(2):109-17. PubMed ID: 20444035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.
    Dawson A; Davies JI; Struthers AD
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study.
    de Pouvourville G; Solesse A; Beillat M
    Arch Cardiovasc Dis; 2008 Sep; 101(9):515-21. PubMed ID: 19041835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aldosterone in heart failure: pathophysiology and treatment.
    Struthers AD
    Curr Heart Fail Rep; 2004 Dec; 1(4):171-5. PubMed ID: 16036041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mineralocorticoid Receptor Antagonists for Treatment of Hypertension and Heart Failure.
    Sica DA
    Methodist Debakey Cardiovasc J; 2015; 11(4):235-9. PubMed ID: 27057293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aldosterone antagonists in the treatment of heart failure.
    Marcy TR; Ripley TL
    Am J Health Syst Pharm; 2006 Jan; 63(1):49-58. PubMed ID: 16373465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure.
    Zannad F; Radauceanu A
    Heart Fail Rev; 2005 Jan; 10(1):71-8. PubMed ID: 15947894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of agents that affect aldosterone action.
    Tamargo J; Solini A; Ruilope LM
    Semin Nephrol; 2014 May; 34(3):285-306. PubMed ID: 25016400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diastolic heart failure in the elderly and the potential role of aldosterone antagonists.
    Kumar A; Meyerrose G; Sood V; Roongsritong C
    Drugs Aging; 2006; 23(4):299-308. PubMed ID: 16732689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aldosterone receptor antagonists.
    Azizi M
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):179-181. PubMed ID: 32473789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The place of aldosterone receptor blockers in the treatment of chronic heart failure].
    Kardiologiia; 2005; 45(10):76-81. PubMed ID: 16234778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aldosterone antagonism in heart failure.
    Miller AB
    Vasc Health Risk Manag; 2007; 3(5):605-9. PubMed ID: 18078011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Are aldosterone antagonists effective in patients with mild to moderate heart failure?].
    Rada G; Peña J
    Medwave; 2014 Jul; 14(6):e5999. PubMed ID: 25353251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aldosterone receptor antagonists in cardiovascular disease: a review of the recent literature and insight into potential future indications.
    Markowitz M; Messineo F; Coplan NL
    Clin Cardiol; 2012 Oct; 35(10):605-9. PubMed ID: 22778046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.